Hyris 和 Ulisse Biomed 完成整合，组建新的生物技术集团。 Hyris and Ulisse Biomed completed their integration to form a new biotech group.

Hyris 和 Ulisse Biomed 已完成整合，创建了一个新的国际生物技术集团。 Hyris and Ulisse Biomed have completed their integration, creating a new international biotech group. 此次合作将 Hyris 的颠覆性基因测试平台和 Ulisse Biomed 的创新测试平台结合起来，成为全球生物技术市场创新的新标杆。 The partnership combines Hyris' disruptive genetic testing platform and Ulisse Biomed's innovative testing platforms to become a new benchmark of innovation in the global biotech market. 经过反向收购交易和股东大会后，合并于12月21日正式获得批准。 The merger was officially ratified on December 21st after a reverse take-over transaction and a shareholders' meeting.